GlassScriptPhysician profile
Matthew Wilson
NPI 1548244247
$2,277.08
in general payments reported to CMS, 2019-2025
11 companies · $173 in 2025
The $173 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,315 · 2020: $39.55 · 2021: $88.48 · 2022: $22.48 · 2023: $167 · 2024: $472 · 2025: $173.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $812.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $811.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $689.23 | 2019 | |
| Acell, INC. | $531.36 | 2019-2020 | |
| Integra Lifesciences Corporation | $358.73 | 2021-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Aroa Biosurgery Incorporated | $230.70 | 2024-2025 | |
| Davol INC. | $133.98 | 2023 | Phasix Mesh |
| Amgen INC. | $125.00 | 2024 | Tepezza |
| Si-Bone, INC. | $115.67 | 2019 | |
| Bioventus LLC | $34.80 | 2021-2024 | Durolane |
| Haemonetics Corporation | $22.77 | 2025 | Teg6s Hemostasis System |
| Ethicon US, LLC | $18.18 | 2019 | |
| Solventum Corporation | $16.66 | 2025 | V.A.C. Veraflo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Wilson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.